Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: Two-year follow-up data

Pediatric Nephrology

Volumn 24, Issue 1, 2009, Pages 177-182

  Webb, Nicholas J A ^a   Prokurat, Sylwester ^b   Vondrak, Karel ^c   Watson, Alan R ^d   Hughes, David A ^e   Marks, Stephen D ^f   Moghal, Nadeem E ^g   Fitzpatrick, Maggie M ^h   Milford, David V ⁱ   Saleem, Moin A ^j   Jones, Caroline A ^k   Friman, Styrbjorn ^l   Damme Lombaerts, Rita ^m   Janssen, Françoise ⁿ   Hamer, Clare ^o   Rhodes, Sarah ^p  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d Children/Young People's Kidney Unit   (United Kingdom)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^g ROYAL VICTORIA INFIRMARY   (United Kingdom)

^h ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

ⁱ BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^j BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^k ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^l SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^m UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁿ HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^o MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^p PENNINE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

more..

Author keywords

Acute rejection; Basiliximab; Graft survival; Interleukin 2receptor (IL2R) antibodies; Long term survival; Renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN A; DEFLAZACORT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD PRESSURE MEASUREMENT; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL RATE; TREATMENT RESPONSE; VIRUS INFECTION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CHILD; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PREDNISOLONE; PROSPECTIVE STUDIES; RECOMBINANT FUSION PROTEINS; TACROLIMUS;

EID: 59849099854     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0931-x     Document Type: Article

References (14)

1. Webster AC, Playford EG, Higgins G, Chapman JR, Craig J (2004) Interleukin 2 receptor antagonists for kidney transplant recipient. Cochrane Database Syst Rev (1):CD003897
2. No authors listed (2004) Immunosuppressive therapy for renal transplantation in adults. National Institute for Health and Clinical Excellence
3. Smith JM, Nemeth TL, McDonald RA (2003) Current immunosuppressive agents: Efficacy, side effects and utilization. Pediatr Clin North Am 50:1283-1300
4. Pape L, Strehlau J, Henne T, Latta K, Nashan B, Ehrich JH, Klempnauer J, Offner G (2002) Single centre experiences with basiliximab in paediatric renal transplantation. Nephrol Dial Transplant 17:276-280
5. Swiatecka-Urban A, Garcia C, Feuerstein D, Suzuki S, Devarajan P, Schechner R, Greenstein S, Tellis V, Kaskel F (2001) Basiliximab induction improves the outcome of renal transplants in children and adolescents. Pediatr Nephrol 16:693-696
6. Offner G, Broyer M, Niaudet P, Loirat C, Mentser M, Lemire J, Crocker JF, Cochat P, Clark G, Gerbeau C, Chodoff L, Korn A, Hall M (2002) A multicenter, open-label pharmacokinetic/pharmacodynamic safety and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients. Transplantation 74:961-966
7. Vester U, Kranz B, Testa G (2001) Efficacy and tolerability of interleukin-2 receptor blockage with basiliximab in pediatric renal transplant recipients. Pediatr Transplant 5:297-301
8. Grenda R, Watson A, Vondrak K, Webb NJA, Beattie J, Fitzpatrick M, Saleem MA, Trompeter R, Milford DV, Moghal NE, Hughes D, Perner F, Friman S, Van Damme-Lombaerts R, Janssen F (2006) A prospective, randomized, multicentre trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant 6:1666-1672
9. No authors listed (2001) Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
10. Adu D, Cockwell P, Ives NJ, Shaw J, Wheatley K (2003) Interleukin-2 receptor antibodies in renal transplantation: Meta-analysis of randomized trials. BMJ 326:789
11. Zimmerhackl LB, Jungraithmayr TC, Toenshoff B, Offner G, Faerber L, Mihatsch M (2007) Basiliximab for treatment of acute rejection: First prospective placebo controlled trial in children with 6 month protocol biopsy. A report of the Paediatric Basiliximab Study Group (abstract 154). Pediatr Transplant 11 [Suppl 1]:70
12. Trompeter R, Filler G, Webb NJA, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JHH, Klare B, Zacchello G, Brekke IB, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomised multicentre study comparing tacrolimus with cyclosporin in renal transplantation. Pediatr Nephrol 17:141-149
13. Filler G, Trompeter RS, Webb NJA, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes DA, Offner G, Klare B, Zacchello G, Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) GFR predicts graft survival in paediatric renal recipients: A randomised trial of tacrolimus vs cyclosporin microemulsion. Transplant Proc 34:1935-1938
14. Filler G, Webb NJA, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R (2005) Four year data after paediatric renal transplantation: A randomised trial of tacrolimus vs cyclosporin microemulsion. Pediatr Transplant 9:498-503